BILL vs XENE · rev $1.65B vs $2.55B cap
Bill Com Holdings Inc (BILL) versus Xenon Pharmaceuticals Inc (XENE) — a side-by-side from cached financials, not a winner call.
Bill Com Holdings Inc (BILL) is a software - application company listed on US.
Xenon Pharmaceuticals Inc (XENE) is a biotechnology company listed on US.
Latest reported BILL revenue for 2026-06-30 was $1.65B. Net income was -$11.2M. Revenue was up 13.0% from 2025-06-30 to 2026-06-30. BILL currently screens at market cap $4.78B.
Latest reported XENE revenue for 2026-06-30 was $0. Net income was -$213.0M. XENE currently screens at market cap $2.55B.
BILL currently screens at market cap $4.78B. XENE currently screens at market cap $2.55B.
Not investment advice. Open the BILL and XENE stock pages for the full models.
Not investment advice.